While many people in wealthier countries have been vaccinated against COVID-19, there is still a need for vaccination in much of the world. A new vaccine developed at MIT and Beth Israel Deaconess Medical Center may aid in ...
Mar 16, 2022
0
68
The parasites that cause a disfiguring skin disease affecting about 12 million people globally may have met their match in vaccines developed using CRISPR gene-editing technology, new research suggests.
Mar 16, 2022
0
41
The first 12 study participants have been enrolled in a new Phase 1 clinical trial using the messenger ribonucleic acid (mRNA) vaccine technology developed by Moderna. The study evaluates the safety of and immune responses ...
Mar 14, 2022
0
21
Briefly blocking a key molecule when administering the only approved vaccine for tuberculosis vastly improves long-term protection against the devastating disease in mice, researchers from Texas Biomedical Research Institute ...
Mar 11, 2022
0
45
Exactly two years ago, on March 11 2020, the World Health Organization (WHO) declared COVID-19 a global pandemic.
Mar 11, 2022
0
8
With as much turmoil and negativity as the COVID-19 pandemic has supplied, there may be a silver lining when it comes to a new vaccine study for those suffering with HIV.
Mar 8, 2022
0
53
The University of Oxford and the Ifakara Health Institute today announced the vaccination of the first participants in a Phase Ib/II trial testing a novel rabies vaccine in human volunteers in Tanzania.
Mar 7, 2022
0
6
The leaders of Mayo Clinic's Vaccine Research Group are emphasizing the need for increased long-term study of vaccines and their mechanisms with future safety of patients in mind.
Mar 3, 2022
0
3
Researchers at Massachusetts General Hospital (MGH), in partnership with NYU Langone Health, have launched a multi-center clinical trial to investigate a new treatment for pediatric type 1 diabetes even in subjects with established ...
Mar 1, 2022
0
5
Canadian health authorities approved Thursday the first domestic COVID-19 vaccine, Quebec City-based biopharmaceutical firm Medicago and its partner GlaxoSmithKline announced.
Feb 24, 2022
0
5
